Aclairo Pharmaceutical Development Group at SOT 2027
Mar 14–17, 2027 San Antonio, TX ~4k attendees Website
Aclairo Pharmaceutical Development Group takes part in 2 sessions at SOT 2027 in San Antonio. Its people speak on the regulatory view of minipigs for developmental, reproductive and juvenile toxicity studies, and on safety testing of gene editors delivered in lipid nanoparticles. The Virginia consultancy advises drug developers on nonclinical safety, toxicology and regulatory strategy.
| Organization | SOT 2027 Attendance |
|---|---|
AP Aclairo Pharmaceutical Development Group Vienna, VA | |
Drug development consultancy advising on nonclinical safety, toxicology and regulatory strategy. | Talk Wed, Mar 17 11:45am–12:00pm Talk Wed, Mar 17 3:05pm–3:25pm |
Find decision makers at Aclairo Pharmaceutical Development Group
Tell us what you sell and we’ll find the people at Aclairo Pharmaceutical Development Group most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Society of Toxicology. Organization details are derived from SOT’s published ToxExpo exhibitor list, its online program planner and each exhibitor’s own profile and website. Submit a correction